Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial.

Autor: Hubers SA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. (S.A.H., P.M.M.K., H.H.C.).; Minneapolis Heart Institute, United Hospital, St. Paul (S.A.H.)., Benike SL; Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN. (S.L.B., P.M.M., H.H.C.)., Johnson BK; Quantitative Health Sciences, Mayo Clinic, Rochester, MN. (B.K.J., C.S.)., McKie PM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. (S.A.H., P.M.M.K., H.H.C.).; Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN. (S.L.B., P.M.M., H.H.C.)., Scott C; Quantitative Health Sciences, Mayo Clinic, Rochester, MN. (B.K.J., C.S.)., Chen HH; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. (S.A.H., P.M.M.K., H.H.C.).; Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN. (S.L.B., P.M.M., H.H.C.).

Publikováno v: Circulation. Heart failure [Circ Heart Fail] 2024 Nov 08, pp. e011761. Date of Electronic Publication: 2024 Nov 08.

MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease.

Autor: Ma X; Cardiorenal Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., McKie PM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Iyer SR; Cardiorenal Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Scott C; Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA., Bailey K; Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA., Johnson BK; Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA., Benike SL; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Chen H; Cardiorenal Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Miller WL; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Cabassi A; Department of Medicine and Surgery, University of Parma, Parma, Italy., Burnett JC Jr; Cardiorenal Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA., Cannone V; Cardiorenal Research Laboratory, Mayo Clinic, Rochester, Minnesota, USA.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Department of Medicine and Surgery, University of Parma, Parma, Italy.

Publikováno v: JACC. Basic to translational science [JACC Basic Transl Sci] 2023 Nov 01; Vol. 9 (1), pp. 18-29. Date of Electronic Publication: 2023 Nov 01 (Print Publication: 2024).

Sex-specific cut-off values for soluble suppression of tumorigenicity 2 (ST2) biomarker increase its cardiovascular prognostic value in the community.

Autor: Harmon DM; Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education, Rochester, MN, USA., AbouEzzeddine OF; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA., McKie PM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA., Scott CG; Department of Biostatistics, Mayo Clinic, Rochester, MN, USA., Saenger AK; Department of Laboratory Medicine and Pathology, Hennepin Healthcare/HCMC, Minneapolis, MN, USA.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA., Jaffe AS; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Publikováno v: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2021 Nov; Vol. 26 (7), pp. 639-646. Date of Electronic Publication: 2021 Jul 29.

Artificial Intelligence-Augmented Electrocardiogram Detection of Left Ventricular Systolic Dysfunction in the General Population.

Autor: Kashou AH; Department of Medicine, Mayo Clinic, Rochester, MN., Medina-Inojosa JR; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Noseworthy PA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Rodeheffer RJ; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Lopez-Jimenez F; Department of Medicine, Mayo Clinic, Rochester, MN., Attia IZ; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Kapa S; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Scott CG; Division of Biostatistics, Mayo Clinic, Rochester, MN., Lee AT; Division of Biostatistics, Mayo Clinic, Rochester, MN., Friedman PA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., McKie PM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. Electronic address: mckie.paul@mayo.edu.

Publikováno v: Mayo Clinic proceedings [Mayo Clin Proc] 2021 Oct; Vol. 96 (10), pp. 2576-2586. Date of Electronic Publication: 2021 Jun 10.

STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure.

Autor: Cannone V; Cardiorenal Research Laboratory, Division of Circulatory Failure, Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Ledwidge M; STOP-HF Unit, St Vincent's University Healthcare Group, Dublin, Ireland.; School of Medicine, University College Dublin, Dublin, Ireland., Watson C; UCD Conway Institute, School of Medicine, University College Dublin, Dublin, Ireland.; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland., McKie PM; Cardiorenal Research Laboratory, Division of Circulatory Failure, Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA., Burnett JC Jr; Cardiorenal Research Laboratory, Division of Circulatory Failure, Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA., McDonald K; STOP-HF Unit, St Vincent's University Healthcare Group, Dublin, Ireland.; School of Medicine, University College Dublin, Dublin, Ireland.

Publikováno v: JACC. Basic to translational science [JACC Basic Transl Sci] 2021 Jun 16; Vol. 6 (6), pp. 497-504. Date of Electronic Publication: 2021 Jun 16 (Print Publication: 2021).